MapLight Therapeutics, Inc. Common Stock Defensive Interval Ratio
MapLight Therapeutics, Inc. Common Stock defensive interval ratio. MapLight Therapeutics, Inc. Common Stock (MPLT) has a Defensive Interval Ratio of 4410 days as of June 2026. Defensive assets of $233.09 Million (cash $-, short-term investments $233.09 Million, receivables $-) cover 4410 days of daily cash needs of $52.86K/day. See MPLT working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of MapLight Therapeutics, Inc. Common Stock (2024–2025)
Defensive interval ratio of MapLight Therapeutics, Inc. Common Stock from 2024 to 2025. This chart shows how MapLight Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 4410 days, meaning defensive assets of $233.09 Million can fund 4410 days of operations without new revenue. Check MapLight Therapeutics, Inc. Common Stock liquidity resilience to evaluate the company's liquid asset resilience ratio.
MapLight Therapeutics, Inc. Common Stock Defensive Interval Ratio by Year (2024–2025)
MapLight Therapeutics, Inc. Common Stock defensive interval ratio by year from 2024 to 2025. The table below presents the year-by-year Defensive Interval Ratio for MapLight Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see balance sheet size of MapLight Therapeutics, Inc. Common Stock.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 5811 days | $258.37 Million | $44.46K/day | $- | $258.37 Million | ▲ +4194 days |
| 2024 | 1617 days | $70.54 Million | $43.62K/day | $- | $70.54 Million | — |